Integrating heart care into HIV services in Botswana using statins
Official title: Integrating Hypertension and Cardiovascular Disease Care into Existing HIV Service Package in Botswana (InterCARE)-Statin Sub-study
Funded at University of Botswana · NIH-11539151 · Data updated 2026-11-12
This project tests a simple, scalable approach to help people with HIV in Botswana start and stay on statin therapy to prevent heart attacks and strokes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Botswana NIH-funded |
| Lab location | 1 site (Gaborone, Botswana) |
| Project start | September 1, 2025 |
| Project end | June 30, 2030 |
| Funding year | 2026 |
| Award (this year) | $32,006 |
| NIH project number | 3R01HL182509-02S1 |
| Project ID | NIH-11539151 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults living with HIV in Botswana who are eligible for statin therapy and are receiving HIV care.
✕Less likely to help
Individuals without HIV or without indication for statin therapy, or those unable to participate due to medical contraindications, may not benefit.
What this research studies
If people living with HIV can reliably access statin therapy within their existing HIV care, they may have fewer heart problems and better overall health. The study will test a multi-component, community-based way to deliver statins and manage hypertension, using a straightforward age and hypertension status approach rather than complex risk scores. By focusing on a setting with high HIV prevalence, the research aims to show how integrated care can be scaled in resource-limited environments and inform similar efforts in other countries. The results could guide policies to reduce cardiovascular disease among people with HIV in Botswana and beyond.
Why it matters
Potential benefit: If successful, patients with HIV could experience reduced risk of heart attacks and strokes through easier access to and persistence with statin therapy.
How similar studies have gone: Previous work shows that streamlined, integrated care can improve medication uptake in similar settings, though this exact HIV-CVD integration in Botswana is innovative.
Where this research is happening
-
University of Botswana
Gaborone, Botswana Active
Researchers
- Principal investigator: Mosepele, Mosepele — University of Botswana
- Study coordinator: Mosepele, Mosepele
Related research
Other NIH-funded projects on the same topics.
-
A heart-healthy program for aging HIV patients using therapy pets to help blood pressure
A study tests whether using the human-animal bond from dog ownership can help older adults living with HIV control their blood pressure and improve heart health.
-
Integrating heart-attack and stroke prevention with HIV care in Botswana
A study tests a simple, scalable plan to help people with HIV in Botswana get statins to prevent heart problems.
-
Hypertension care for Veterans with rheumatoid arthritis to prevent heart disease
A structured plan to improve blood pressure control in Veterans with rheumatoid arthritis to lower their risk of heart disease.
-
Understanding how daily social stress relates to hypertension and heart disease
A study will look at how everyday social stress affects blood pressure and heart disease risk in adults, especially among African American participants.
-
Identifying blood proteins that indicate blood pressure changes during exercise and their link to heart disease.
This study is looking at how your blood pressure changes when you exercise to find hidden heart risks that you might not notice when you're just resting, and it’s for anyone interested in understanding their heart health better.
-
Improving hypertension care for people living with HIV in Botswana
This study is working to help people living with HIV in Botswana who also have high blood pressure by improving their care and treatment, so they can feel healthier and better manage both conditions together.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.